Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report
Newborn screening (NBS) for mucopolysaccharidosis type I (MPS I, Hurler syndrome) is currently conducted in about two-fifths of the NBS programs in the United States and in a few other countries. Screening is performed by measurement of residual activity of the enzyme <i>alpha</i>-<sp...
| Hlavní autoři: | , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
MDPI AG
2020-10-01
|
| Edice: | International Journal of Neonatal Screening |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2409-515X/6/4/78 |